Biocept (BIOC) Misses Q1 EPS by 2c

Biocept (NASDAQ: BIOC) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $1.1 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance